Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Deferred Taxes (2019 - 2025)

CorMedix's Deferred Taxes history spans 3 years, with the latest figure at -$59.7 million for Q3 2025.

  • For Q3 2025, Deferred Taxes changed N/A year-over-year to -$59.7 million; the TTM value through Sep 2025 reached -$59.7 million, changed N/A, while the annual FY2025 figure was -$28.9 million, N/A changed from the prior year.
  • Deferred Taxes for Q3 2025 was -$59.7 million at CorMedix, down from $2206.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at -$59.7 million in Q3 2025 and bottomed at -$59.7 million in Q3 2025.